Vidavo SA
AATHEX:VIDAVO9.95
EUR
-0.05
(-0.50%)
ISIN
GRS511003006
Return %
Stock
S&P 500
1Y
84.26
14.20
3Y
436.64
81.12
5Y
141.97
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Markela G. Psimarnou
- Full Time Employees
- 15
- Sector
- Technology services
- Industry
- Information technology services
- Address
- Thessaloniki Greece
- IPO Date
- Mar 18, 2010
- Website
- vidavo.eu
- Similar Companies
- Business
- Vidavo S.A. is a Greece-based digital health and telemedicine technology company that develops, deploys, and manages connected care platforms and medical software solutions. Founded in 2002 and headquartered in Thessaloniki, Greece, the company is publicly listed on the Athens Stock Exchange (ATHEX: VIDAVO) and operates across Greece and the broader European market, serving public and private healthcare organizations, medical practices, health insurers, corporate employers, and clinical research institutions. The company's primary technology offering centers on Vida24, a proprietary, cloud-based, CE-certified Class IIa medical device ecosystem engineered for remote care delivery, clinical data management, and continuous patient monitoring. Vidavo delivers a structured portfolio of products and related professional services comprising: Vida24 Telemedicine, an encrypted digital communication module facilitating remote patient-doctor consultations, digital appointment scheduling, and electronic prescription workflows; Vida24 Remote Patient Monitoring (RPM) and Chronic Care Management, an integrated platform for capturing, evaluating, and alerting on physiological parameters for patients with chronic conditions, including diabetes, arterial hypertension, heart failure, and chronic obstructive pulmonary disease (COPD); Vidaware, a companion wearable application for smartwatches and Wear OS devices enabling mobile electrocardiogram (ECG) recording and biometric tracking; Vida24 InsurTech, a specialized digital health suite designed for life and health insurance carriers to manage policyholder risk, wellness incentives, and preventative health monitoring; Vida24 Corporate Wellness, an employee health and lifestyle monitoring solution; and Clinical Decision Support Systems (CDSS) for automated triage and hospital emergency department support. Complementing its product suite, Vidavo provides strategic digital health advisory; bespoke software development and white-label deployments; interoperability integrations with electronic health records (EHR) and hospital information systems (HIS); and post-deployment technical maintenance, clinical training, and regulatory data compliance services. In recent strategic and operational developments, Vidavo completed capital raising activities specifically designated to accelerate the international expansion of its global partner and reseller ecosystem. The company has modernized its core software architecture by introducing artificial intelligence (AI)-driven modules for patient engagement, predictive symptom tracking, and automated educational interventions. Vidavo has also expanded its commercial scope into the insurance sector with the formal rollout and deployment of its dedicated Vida24 InsurTech solution. Additionally, the company continues to broaden its technological capabilities through ongoing participation in European Union-funded research and innovation programs focused on healthcare artificial intelligence, cybersecurity in telehealth infrastructure, and value-based integrated care solutions.